ATC
RPRX icon

Argent Trust Co’s Royalty Pharma RPRX Stock Holding History

Argent Trust Co’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,259
Closed -$220K – 728
2024
Q1 		$220K Hold
7,259
– – 0.01% 631
2023
Q4 		$204K Sell
7,259
-236
-3% -$6.49K 0.01% 594
2023
Q3 		$203K Sell
7,495
-1,500
-17% -$44.6K 0.01% 581
2023
Q2 		$277K Buy
8,995
+1,171
+15% +$39.7K 0.02% 514
2023
Q1 		$282K Sell
7,824
-744
-9% -$27.6K 0.02% 434
2022
Q4 		$339K Buy
8,568
+300
+4% +$12.5K 0.02% 404
2022
Q3 		$332K Sell
8,268
-45
-0.5% -$1.92K 0.02% 406
2022
Q2 		$349K Sell
8,313
-114
-1% -$4.67K 0.02% 403
2022
Q1 		$328K Sell
8,427
-275
-3% -$10.8K 0.02% 433
2021
Q4 		$347K Buy
+8,702
New +$338K 0.02% 436

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Argent Trust Co's RPRX Position: Q2 2024 in Review

Argent Trust Co sold out of Royalty Pharma (RPRX) in Q2 2024, closing a stake of 7,259 shares — an estimated $220K sold.

Argent Trust Co first reported a position in RPRX in Q4 2021 and held it in 10 quarters. The position peaked at $349K in Q2 2022. 378 funds tracked by Wall St. Rank hold RPRX as of Q2 2024.

  • Argent Trust Co reported no remaining Royalty Pharma position as of Q2 2024 after selling out during the quarter.
  • Argent Trust Co sold 7,259 Royalty Pharma shares in Q2 2024, an estimated $220K.
  • Argent Trust Co first reported a position in Royalty Pharma in Q4 2021 and held it in 10 quarters.
  • Argent Trust Co's Royalty Pharma position peaked at $349K in Q2 2022.
  • 378 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2024.

Based on Argent Trust Co's 13F filing for Q2 2024, filed 12 Aug 2024.